A Dual-Antigen Targeting, Hypoimmune Allogeneic CAR T to Evade Innate and Adaptive Immune Rejection and Overcome Antigen Escape

Adam Johnson(Sana Biotechnology (United States)), Aaron E. Foster(Medpace (United States)), Terry J. Fry(University of Colorado Anschutz Medical Campus), Neal Van Hoeven(Sana Biotechnology (United States)), Jesus Moreno(Sana Biotechnology (United States)), Hallee Wright(Sana Biotechnology (United States)), Meghan Lamba(Sana Biotechnology (United States)), Chi Young(Sana Biotechnology (United States)), Ouwen Liang(Sana Biotechnology (United States)), Brian Granger(Sana Biotechnology (United States)), Xiaomeng Hu(Huzhou University), Sonja Schrepfer(Cedars-Sinai Medical Center), Andrew McAlister(University of Auckland)
Blood
November 15, 2022
Cited by 2


Related Papers